Replies to post #129712 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

.....this trial still should have reached 248 events much sooner than February 2017. -- Senti

[Tadasana]

nice senti, PFS is not confounded and with 83 PFS patients as of Feb.2017 leaves little doubt that most all 83 should be from treatment arm. There is efficacy, and statistically significant. OS may be confounded but seeing how there is 100 alive with most not having progression would seem like non progression is the key to survival... that's why OS rates have gone down dramatically.. imho Will be so sweet when we unblind... thanks for all your analysis...

[hankmanhub]

So starting with April 2015, not Feb 2015, if the blended PFS should have been on average, 11 months, then if all 248 patients had evented based on that 11 month average, they would have done so by February 2016.

Senti, so what exactly makes you so sure that in fact they didn't hit 248 back in Feb 2016 but did not announce it? Could they have been playing cute back in Dec 2016?